ESC 365 - CDK4/6 inhibitor ribociclib induces cardiotoxicity in dynamic engineered heart tissues, mitigated by E2F1 overexpression

CBS PREMIUM ACCESS

CDK4/6 inhibitor ribociclib induces cardiotoxicity in dynamic engineered heart tissues, mitigated by E2F1 overexpression

Session: The immune system in the pathogenesis and treatment of cancer therapy-induced cardiovascular toxicity

Topic: Stem Cells, Cell Cycle, Cell Senescence, Cell Death

Speaker: Mr I. Dias (Groningen, NL)

Event: Frontiers in CardioVascular Biomedicine 2024

Congress Presentation

Add to my library

About the speaker

Mr Itamar Dias

University Medical Centre Groningen, Groningen (Netherlands (The))

0 follower

3 more presentations in this session

Cardioprotection via modulation of the immune response

Speaker: Doctor Z. Varga (Budapest, HU)

Cancer therapies and vascular toxicities

Speaker: Professor I. Andreadou (Athens, GR)

Accelerated atherosclerosis by immune checkpoint inhibitors

Speaker: Doctor N. Van Es (Amsterdam, NL)

Access the full session

The immune system in the pathogenesis and treatment of cancer therapy-induced cardiovascular toxicity

Speakers: Mr I. Dias, Doctor Z. Varga, Professor I. Andreadou, Doctor N. Van Es

About the event

Frontiers in CardioVascular Biomedicine 2024

12 April - 14 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources